Latest Insomnia Treatment News

Page 2 of 2

Avecho Addresses ASX Price Query Amid Speculation on CBD Trial Milestone

Avecho Biotechnology has responded to an ASX price query, confirming no undisclosed information exists to explain recent trading spikes, while highlighting market speculation linked to its Phase III CBD insomnia trial.

Ada Torres

14 Feb 2025

Browse the archive

Full archive

Aug 2026 July 2026 June 2026 May 2026 Apr 2026 Mar 2026 Feb 2026 Jan 2026